Morgenthaler Closes Ninth Fund at $4...(ed as chief technology officer andengine...),Health

Date:11/12/2008

ed as chief technology officer and engineering manager, and helped grow the company to over 400 enterprise customers and over 1 million licensed users. He also currently serves as a consulting assistant professor at Stanford University in the Computer Systems Lab. Appenzeller holds 15 issued or pending patents and was named a Technology Pioneer by the World Economic Forum in 2006. He holds a degree in physics from the University of Karlsruhe in Germany and M.S. and Ph.D. degrees in computer science from Stanford University.

Lynn and Appenzeller join the IT Team that now includes partners Ken Gullicksen, Drew Lanza, Gary Little, Gary Morgenthaler and Bob Pavey. "Adding Rebecca and Guido to our team will strengthen our ties to emerging entrepreneurs in the Bay Area," said Gary Little. "Despite entrepreneurial efforts elsewhere in the world, we believe the best place to build major new ventures with international scope continues to be Silicon Valley."

Life-Science Investing -- Doug Treco Joins LS Team

Morgenthaler's Life Science Team has named Doug Treco, Ph.D., as an EIR in its Boston office. Treco co-founded Transkaryotic Therapies, a multi-platform biopharmaceutical company which was acquired in 2005 by Shire plc. He also currently serves as a visiting scientist at the Department of Molecular Biology at Massachusetts General Hospital. Treco has authored numerous peer-reviewed publications and holds 35 US and European patents in the areas of protein production, gene mapping and gene therapy. He received a Ph.D. in biochemistry and molecular biology from the State University of New York at Stony Brook and performed his post-doctoral studies at Massachusetts General Hospital.

Treco joins the Life Science Team that now includes partners, Robin Bellas, Jim Broderick, M.D., Ralph "Chris" Christoffersen, Ph.D., Nassim Usman, Ph.D. (EIR) and Hank Plain. Plain joined Morgenthaler in 2007 after more than 25 years in the life science industry, inclu
'/>"/>

SOURCE Morgenthaler Ventures Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4
Related medicine news :

1. Intelect Medical Closes $11 Million in Funding from Boston Scientific and Greatbatch for Stroke and TBI Recovery Clinical Trials
2. Thermage Discloses Preliminary 3Q 2008 Results for Thermage and Reliant
3. Response Biomedical Closes $5.1 Million Financing
4. Blue Cross Blue Shield of Michigan Closes Detroit Operations October 31 Due to Bomb Threat
5. Oaks Development Group Closes on 2.1 Acres for Medical Office Building in Palm Coast, FL
6. Patient Safety Technologies Closes on $2.325 Million in Equity Financing
7. Aduromed Closes Restructuring and Raises $3.8 Million of New Equity Capital
8. Immucor Closes BioArray Acquisition
9. NBTY Closes on Purchase of Leiner Health Products
10. Retired Respironics Chairman Jerry McGinnis and Renal Solutions CEO Pete DeComo Join ALung Technologies Board of Directors; ALung Closes on $1 Million Bridge Financing
11. Oaks Development Group Closes on Second San Antonio Project